Alessandra Pescarollo
About
In The Last Decade
Alessandra Pescarollo
11 papers receiving 480 citations
Peers
Comparison fields: 5 of 35
- Oncology 308
- Genetics 216
- Molecular Biology 171
- Hematology 167
- Immunology 163
Countries citing papers authored by Alessandra Pescarollo
This map shows the geographic impact of Alessandra Pescarollo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Pescarollo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Pescarollo more than expected).
Fields of papers citing papers by Alessandra Pescarollo
This network shows the impact of papers produced by Alessandra Pescarollo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Pescarollo. The network helps show where Alessandra Pescarollo may publish in the future.
Co-authorship network of co-authors of Alessandra Pescarollo
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Pescarollo. A scholar is included among the top collaborators of Alessandra Pescarollo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Pescarollo. Alessandra Pescarollo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 30 | |
| 3 | 1 | |
| 4 | 133 | |
| 5 | 1 | |
| 6 | 155 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 159 | |
| 10 | Complete haematological response with granulocyte colony stimulating factor (G-CSF) and hydroxyurea in relapsed acute myeloid leukaemia (AML) of the elderly. | 1 |
| 11 | Allografting for patients with advanced hematological malignancies: non-myeloablative conditioning followed by the reinfusion of lymphocytes engineered with hsv thymidine kinase gene | 1 |
| 12 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.